recurrent or metastatic Adenoid Cystic Carcinoma of the Head and Neck research hub

Randomized, non-comparative, open-label early phase Ib study with OBT076 or OBT076 followed by Balstilimab in patients with Adenoid Cystic Carninoma of the Head and Neck

This study is for people in the UK with a specific type of head and neck cancer called Adenoid Cystic Carcinoma that has come back or spread. It's an early-stage study testing new medicines, OBT076 alone or with Balstilimab, to see how safe they are and how they affect the body.